Professor dr. Mark I. van Berge Henegouwen is chair of the Dutch Upper GI Cancer Audit and chair of the Dutch society of foregut surgeons of the Netherlands.

Mark van Berge Henegouwen’ s clinical practice is dedicated to patients with malignancies of the esophagus and stomach. The Amsterdam UMC is currently one of the largest centers for esophageal and gastric cancer in Europe. The Amsterdam UMC is a tertiary referral center for these patients with around 250 esophago-gastric resections annually. Mark van Berge Henegouwen has introduced minimally invasive surgery for esophageal and gastric cancer at his center in 2009 and now around 90 percent of patients is treated thoraco-laparoscopically or robotically.